Your session is about to expire
← Back to Search
THC + CBD for Chronic Kidney Disease (POT-GFR-PK Trial)
POT-GFR-PK Trial Summary
This trial tests the effects of THC and CBD on healthy adults and those with chronic kidney disease, including those on dialysis.
POT-GFR-PK Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPOT-GFR-PK Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.POT-GFR-PK Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- You have had a serious bad reaction to using cannabis.You have a history of serious mental health issues like psychosis or mania.You have used any form of marijuana or synthetic cannabinoids in the last 30 days.You are taking medication that can interact with THC or CBD.Your liver is not working properly, as shown by specific blood test results.You have significantly changed your weight in the last 4 weeks.You experienced low blood pressure during dialysis that needed treatment in the last 4 weeks.Your body mass index is below 20 or above 35.You are addicted to any drug except for caffeine or nicotine.You are older than 25 years old.Your kidney function, measured by eGFR, should be within a certain range. If you are on hemodialysis, it should be through a tunnelled catheter for at least 3 hours per session, at least 2 times per week for more than 90 days.
- Group 1: THC/CBD
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the use of THC/CBD officially backed by regulatory approval?
"Our in-house team has rated the safety of THC/CBD to be a 1, signifying limited evidence for both efficacy and security."
Are any slots for enrollment in this research still available?
"As per clinicaltrials.gov, this medical experiment is now recruiting volunteers. The study was first posted on January 11th 2023 and modified most recently on February 14th of the same year."
To what extent is this experiment being utilized by participants?
"Affirmative. According to clinicaltrials.gov, this experiment is currently recruiting individuals who meet the criteria of participation. The study was initially posted on November 1st 2023 and has since been edited on February 14th 2023; 24 volunteers are required across a single site."
Share this study with friends
Copy Link
Messenger